| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 5.04e-06 | 20 | 117 | 4 | GO:0061665 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 5.71e-05 | 36 | 117 | 4 | GO:0019789 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 2.09e-04 | 50 | 117 | 4 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 2.63e-04 | 53 | 117 | 4 | GO:0016859 | |
| GeneOntologyMolecularFunction | calcium ion binding | VIL1 EPS15 PCDHB15 PCDHB14 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB7 ADGRV1 PCDHB16 MMRN1 VCAN | 4.48e-04 | 749 | 117 | 13 | GO:0005509 |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 1.13e-07 | 9 | 115 | 4 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 1.88e-07 | 10 | 115 | 4 | GO:1903301 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 6.31e-07 | 13 | 115 | 4 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 8.79e-07 | 14 | 115 | 4 | GO:1903299 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 4.15e-06 | 20 | 115 | 4 | GO:0006607 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | PCDHB15 PCDHB14 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB16 | 1.02e-05 | 187 | 115 | 8 | GO:0007156 |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 1.14e-05 | 53 | 115 | 5 | GO:0016339 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 5.85e-05 | 38 | 115 | 4 | GO:0000413 | |
| GeneOntologyBiologicalProcess | mRNA transport | 1.63e-04 | 145 | 115 | 6 | GO:0051028 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 6.41e-08 | 8 | 117 | 4 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 1.91e-07 | 10 | 117 | 4 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 8.93e-07 | 14 | 117 | 4 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 2.68e-06 | 18 | 117 | 4 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 4.21e-06 | 20 | 117 | 4 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 5.18e-06 | 21 | 117 | 4 | GO:0106068 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | AKAP6 RGPD2 SYNRG RANBP2 ANK2 SPP1 RGPD1 APC XIAP ADGRV1 CMYA5 TRIP10 AXIN1 RGPD3 SEC23IP TNRC6A HEATR5B | 1.74e-05 | 934 | 117 | 17 | GO:0048471 |
| GeneOntologyCellularComponent | nuclear pore | 2.22e-05 | 101 | 117 | 6 | GO:0005643 | |
| GeneOntologyCellularComponent | inclusion body | 1.52e-04 | 90 | 117 | 5 | GO:0016234 | |
| GeneOntologyCellularComponent | PR-DUB complex | 1.85e-04 | 4 | 117 | 2 | GO:0035517 | |
| GeneOntologyCellularComponent | nuclear body | ZC3H14 NRIP1 AFF2 EP400 ZC3H13 WRN CMYA5 ATF7IP SCAF11 HEATR5B POU2F3 RNF111 NPAT | 1.64e-03 | 903 | 117 | 13 | GO:0016604 |
| GeneOntologyCellularComponent | mismatch repair complex | 1.65e-03 | 11 | 117 | 2 | GO:0032300 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | PMS1 NUP50 RGPD2 NRIP1 RANBP2 AFF2 EP400 RGPD1 ASH2L JMJD1C BAP1 FANCI RGPD3 BICRAL ASXL2 NUP188 MYB | 1.69e-03 | 1377 | 117 | 17 | GO:0140513 |
| HumanPheno | Alternating esotropia | 4.09e-05 | 10 | 37 | 3 | HP:0001137 | |
| HumanPheno | Cephalohematoma | 4.09e-05 | 10 | 37 | 3 | HP:0012541 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 3.14e-06 | 16 | 93 | 4 | MP:0003701 | |
| MousePheno | increased respiratory system tumor incidence | 6.97e-06 | 107 | 93 | 7 | MP:0010298 | |
| MousePheno | increased lung tumor incidence | 6.97e-06 | 107 | 93 | 7 | MP:0008014 | |
| MousePheno | increased lung carcinoma incidence | 1.29e-05 | 78 | 93 | 6 | MP:0008714 | |
| MousePheno | abnormal morula morphology | 2.45e-05 | 26 | 93 | 4 | MP:0012058 | |
| MousePheno | decreased tumor latency | 4.41e-05 | 30 | 93 | 4 | MP:0010308 | |
| MousePheno | increased carcinoma incidence | 4.94e-05 | 197 | 93 | 8 | MP:0002038 | |
| MousePheno | failure of blastocyst formation | 5.03e-05 | 31 | 93 | 4 | MP:0012129 | |
| MousePheno | aneuploidy | 5.18e-05 | 61 | 93 | 5 | MP:0004024 | |
| MousePheno | increased sarcoma incidence | 5.94e-05 | 102 | 93 | 6 | MP:0002032 | |
| MousePheno | abnormal tumor latency | 7.31e-05 | 34 | 93 | 4 | MP:0010307 | |
| MousePheno | increased hepatocellular carcinoma incidence | 1.01e-04 | 70 | 93 | 5 | MP:0003331 | |
| MousePheno | increased physiological sensitivity to xenobiotic | 1.19e-04 | 286 | 93 | 9 | MP:0008873 | |
| MousePheno | abnormal blastocyst formation | 1.26e-04 | 39 | 93 | 4 | MP:0012128 | |
| MousePheno | increased malignant tumor incidence | 1.79e-04 | 237 | 93 | 8 | MP:0002018 | |
| MousePheno | abnormal chromosome number | 2.66e-04 | 86 | 93 | 5 | MP:0004023 | |
| MousePheno | increased incidence of tumors by chemical induction | 3.51e-04 | 141 | 93 | 6 | MP:0004499 | |
| MousePheno | abnormal incidence of induced tumors | 4.20e-04 | 269 | 93 | 8 | MP:0013151 | |
| MousePheno | abnormal CD5-positive gamma-delta T cell number | 4.32e-04 | 5 | 93 | 2 | MP:0013419 | |
| MousePheno | abnormal sex determination | PRAMEF7 RGPD2 ZC3H14 SP4 RANBP2 MAGEL2 RGPD1 APC ADGRV1 PRAMEF8 JMJD1C MLH3 ZNF296 FANCI RGPD3 MYBL1 | 4.61e-04 | 945 | 93 | 16 | MP:0002210 |
| Domain | Cadherin_C | PCDHB15 PCDHB14 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB16 | 1.84e-10 | 42 | 117 | 8 | IPR032455 |
| Domain | Cadherin_C_2 | PCDHB15 PCDHB14 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB16 | 1.84e-10 | 42 | 117 | 8 | PF16492 |
| Domain | Ran_BP1 | 6.77e-09 | 12 | 117 | 5 | PF00638 | |
| Domain | RANBD1 | 6.77e-09 | 12 | 117 | 5 | PS50196 | |
| Domain | Cadherin_2 | PCDHB15 PCDHB14 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB16 | 6.98e-09 | 65 | 117 | 8 | PF08266 |
| Domain | Cadherin_N | PCDHB15 PCDHB14 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB16 | 6.98e-09 | 65 | 117 | 8 | IPR013164 |
| Domain | RanBD | 1.09e-08 | 13 | 117 | 5 | SM00160 | |
| Domain | Ran_bind_dom | 1.09e-08 | 13 | 117 | 5 | IPR000156 | |
| Domain | Cadherin_CS | PCDHB15 PCDHB14 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB16 | 4.18e-07 | 109 | 117 | 8 | IPR020894 |
| Domain | CADHERIN_1 | PCDHB15 PCDHB14 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB16 | 5.51e-07 | 113 | 117 | 8 | PS00232 |
| Domain | Cadherin | PCDHB15 PCDHB14 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB16 | 5.51e-07 | 113 | 117 | 8 | PF00028 |
| Domain | CADHERIN_2 | PCDHB15 PCDHB14 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB16 | 5.90e-07 | 114 | 117 | 8 | PS50268 |
| Domain | - | PCDHB15 PCDHB14 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB16 | 5.90e-07 | 114 | 117 | 8 | 2.60.40.60 |
| Domain | CA | PCDHB15 PCDHB14 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB16 | 6.31e-07 | 115 | 117 | 8 | SM00112 |
| Domain | Cadherin-like | PCDHB15 PCDHB14 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB16 | 6.74e-07 | 116 | 117 | 8 | IPR015919 |
| Domain | Cadherin | PCDHB15 PCDHB14 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB16 | 7.68e-07 | 118 | 117 | 8 | IPR002126 |
| Domain | Rab_bind | 8.23e-06 | 7 | 117 | 3 | PF16704 | |
| Domain | GCC2_Rab_bind | 8.23e-06 | 7 | 117 | 3 | IPR032023 | |
| Domain | - | 2.78e-05 | 10 | 117 | 3 | 1.10.220.60 | |
| Domain | Grip | 3.81e-05 | 11 | 117 | 3 | SM00755 | |
| Domain | GRIP | 3.81e-05 | 11 | 117 | 3 | PF01465 | |
| Domain | Tscrpt_reg_Wos2-domain | 3.89e-05 | 2 | 117 | 2 | IPR012642 | |
| Domain | LMSTEN | 3.89e-05 | 2 | 117 | 2 | PF07988 | |
| Domain | GRIP_dom | 5.06e-05 | 12 | 117 | 3 | IPR000237 | |
| Domain | GRIP | 5.06e-05 | 12 | 117 | 3 | PS50913 | |
| Domain | Cmyb_C | 1.16e-04 | 3 | 117 | 2 | PF09316 | |
| Domain | C-myb_C | 1.16e-04 | 3 | 117 | 2 | IPR015395 | |
| Domain | DNA_mis_repair | 1.16e-04 | 3 | 117 | 2 | SM01340 | |
| Domain | DNA_MISMATCH_REPAIR_1 | 2.32e-04 | 4 | 117 | 2 | PS00058 | |
| Domain | DNA_mismatch_repair_C | 2.32e-04 | 4 | 117 | 2 | IPR013507 | |
| Domain | DNA_mismatch_repair_fam | 2.32e-04 | 4 | 117 | 2 | IPR002099 | |
| Domain | DNA_mis_repair | 2.32e-04 | 4 | 117 | 2 | PF01119 | |
| Domain | DNA_mismatch_repair_CS | 3.84e-04 | 5 | 117 | 2 | IPR014762 | |
| Domain | HTH_MYB | 1.36e-03 | 9 | 117 | 2 | PS51294 | |
| Domain | Myb_dom | 1.36e-03 | 9 | 117 | 2 | IPR017930 | |
| Domain | MYB_LIKE | 1.72e-03 | 38 | 117 | 3 | PS50090 | |
| Domain | EH | 2.06e-03 | 11 | 117 | 2 | PS50031 | |
| Domain | EH | 2.06e-03 | 11 | 117 | 2 | SM00027 | |
| Domain | EH_dom | 2.06e-03 | 11 | 117 | 2 | IPR000261 | |
| Domain | SANT | 3.79e-03 | 50 | 117 | 3 | SM00717 | |
| Domain | SANT/Myb | 4.24e-03 | 52 | 117 | 3 | IPR001005 | |
| Domain | zf-RING_2 | 4.24e-03 | 52 | 117 | 3 | PF13639 | |
| Domain | HATPase_c | 5.58e-03 | 18 | 117 | 2 | SM00387 | |
| Domain | HATPase_c | 6.21e-03 | 19 | 117 | 2 | PF02518 | |
| Domain | PRAME_family | 6.21e-03 | 19 | 117 | 2 | IPR026271 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 1.94e-09 | 41 | 76 | 7 | MM15200 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 7.15e-09 | 49 | 76 | 7 | MM14837 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 6.67e-08 | 40 | 76 | 6 | MM14945 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 9.03e-08 | 42 | 76 | 6 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 1.05e-07 | 43 | 76 | 6 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 1.81e-07 | 47 | 76 | 6 | MM14939 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 2.64e-07 | 50 | 76 | 6 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 2.98e-07 | 51 | 76 | 6 | MM15151 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 4.72e-07 | 55 | 76 | 6 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 6.51e-07 | 58 | 76 | 6 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 6.51e-07 | 58 | 76 | 6 | MM14736 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 1.29e-06 | 65 | 76 | 6 | MM15147 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 2.25e-06 | 18 | 76 | 4 | MM1549 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 2.57e-06 | 73 | 76 | 6 | MM14948 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 5.09e-06 | 82 | 76 | 6 | MM15394 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 5.85e-06 | 84 | 76 | 6 | MM14929 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 6.71e-06 | 86 | 76 | 6 | MM15413 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 9.92e-06 | 92 | 76 | 6 | MM14951 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 3.38e-05 | 114 | 76 | 6 | MM15361 | |
| Pathway | REACTOME_SUMOYLATION | 3.43e-05 | 169 | 76 | 7 | MM14919 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 1.02e-04 | 271 | 76 | 8 | MM15406 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 4.12e-04 | 65 | 76 | 4 | M39682 | |
| Pathway | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | 6.67e-04 | 32 | 76 | 3 | M29579 | |
| Pathway | REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS | 7.31e-04 | 33 | 76 | 3 | M27016 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 7.84e-04 | 77 | 76 | 4 | M27226 | |
| Pathway | REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN | 7.99e-04 | 34 | 76 | 3 | M27041 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 8.71e-04 | 35 | 76 | 3 | M27320 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 9.14e-04 | 139 | 76 | 5 | M715 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 9.46e-04 | 36 | 76 | 3 | M26974 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 9.46e-04 | 36 | 76 | 3 | M27245 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 1.03e-03 | 37 | 76 | 3 | M1029 | |
| Pathway | WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING | 1.03e-03 | 37 | 76 | 3 | M39817 | |
| Pathway | REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS | 1.03e-03 | 37 | 76 | 3 | M27038 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 1.20e-03 | 39 | 76 | 3 | M27238 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_AXIN_TO_WNT_SIGNALING_PATHWAY | 1.26e-03 | 10 | 76 | 2 | M47486 | |
| Pathway | REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS | 1.39e-03 | 41 | 76 | 3 | M29574 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 1.49e-03 | 42 | 76 | 3 | M27272 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.59e-03 | 43 | 76 | 3 | M26975 | |
| Pathway | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | 1.70e-03 | 44 | 76 | 3 | M109 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_APC_TO_WNT_SIGNALING_PATHWAY | 1.83e-03 | 12 | 76 | 2 | M47410 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 1.94e-03 | 46 | 76 | 3 | M27397 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 1.94e-03 | 46 | 76 | 3 | MM14933 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 2.06e-03 | 47 | 76 | 3 | M27395 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 2.07e-03 | 100 | 76 | 4 | MM14561 | |
| Pubmed | PCDHB15 PCDHB14 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB16 | 1.80e-15 | 20 | 119 | 8 | 11322959 | |
| Pubmed | EHBP1 RGPD2 NRIP1 EPS15 RANBP2 HAUS6 RGPD1 APC CHEK1 BCR JMJD1C BAP1 ZFHX4 ATF7IP RGPD3 SEC23IP TNRC6A NPAT | 5.79e-15 | 418 | 119 | 18 | 34709266 | |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | PCDHB15 PCDHB14 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB16 | 2.13e-11 | 57 | 119 | 8 | 32633719 |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | PCDHB15 PCDHB14 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB16 | 2.46e-11 | 58 | 119 | 8 | 30377227 |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | PCDHB15 PCDHB14 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB16 | 9.22e-11 | 68 | 119 | 8 | 11230163 |
| Pubmed | RGPD2 EPS15 RANBP2 MIA3 ANK2 RGPD1 APC MPDZ GRIA3 SIK3 BCR CDC42BPB ATF7IP TAX1BP1 RGPD3 SEC23IP OTUD4 QSER1 NOP2 PRRC2B | 1.07e-10 | 963 | 119 | 20 | 28671696 | |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | PCDHB15 PCDHB14 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB16 | 1.48e-10 | 72 | 119 | 8 | 10380929 |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | PCDHB15 PCDHB14 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB16 | 1.85e-10 | 74 | 119 | 8 | 10817752 |
| Pubmed | PCDHB15 PCDHB14 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB16 | 2.56e-10 | 77 | 119 | 8 | 10835267 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | PCDHB15 PCDHB14 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB16 | 3.49e-10 | 80 | 119 | 8 | 10716726 |
| Pubmed | 5.42e-10 | 13 | 119 | 5 | 12231349 | ||
| Pubmed | EHBP1 RANBP2 HAUS6 MIA3 APC JMJD1C AXIN1 SEC23IP TNRC6A PEAK1 PRRC2B | 1.92e-09 | 263 | 119 | 11 | 34702444 | |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 3.57e-09 | 38 | 119 | 6 | 12791264 | |
| Pubmed | 4.52e-09 | 7 | 119 | 4 | 9037092 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 4.52e-09 | 7 | 119 | 4 | 11353387 | |
| Pubmed | 4.52e-09 | 7 | 119 | 4 | 30944974 | ||
| Pubmed | 4.52e-09 | 7 | 119 | 4 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 4.52e-09 | 7 | 119 | 4 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 4.52e-09 | 7 | 119 | 4 | 17372272 | |
| Pubmed | 4.52e-09 | 7 | 119 | 4 | 38657106 | ||
| Pubmed | 4.52e-09 | 7 | 119 | 4 | 21205196 | ||
| Pubmed | 4.52e-09 | 7 | 119 | 4 | 18949001 | ||
| Pubmed | 4.52e-09 | 7 | 119 | 4 | 25187515 | ||
| Pubmed | 4.52e-09 | 7 | 119 | 4 | 8603673 | ||
| Pubmed | 4.52e-09 | 7 | 119 | 4 | 26632511 | ||
| Pubmed | 4.52e-09 | 7 | 119 | 4 | 24403063 | ||
| Pubmed | 4.52e-09 | 7 | 119 | 4 | 23818861 | ||
| Pubmed | 4.52e-09 | 7 | 119 | 4 | 23536549 | ||
| Pubmed | 4.52e-09 | 7 | 119 | 4 | 12191015 | ||
| Pubmed | 4.52e-09 | 7 | 119 | 4 | 22821000 | ||
| Pubmed | 4.52e-09 | 7 | 119 | 4 | 20682751 | ||
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 9.02e-09 | 8 | 119 | 4 | 21670213 | |
| Pubmed | 9.02e-09 | 8 | 119 | 4 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 9.02e-09 | 8 | 119 | 4 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 9.02e-09 | 8 | 119 | 4 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 9.02e-09 | 8 | 119 | 4 | 28745977 | |
| Pubmed | SLAIN2 EPS15 HAUS6 AFF2 EP400 WRN APC CDC42BPB DMXL1 ATF7IP SEC23IP TNRC6A PEAK1 SMCR8 NOP2 PRRC2B | 1.05e-08 | 777 | 119 | 16 | 35844135 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 1.62e-08 | 9 | 119 | 4 | 18394993 | |
| Pubmed | 1.62e-08 | 9 | 119 | 4 | 28100513 | ||
| Pubmed | 1.62e-08 | 9 | 119 | 4 | 17887960 | ||
| Pubmed | 1.62e-08 | 9 | 119 | 4 | 11553612 | ||
| Pubmed | 1.62e-08 | 9 | 119 | 4 | 10601307 | ||
| Pubmed | 1.62e-08 | 9 | 119 | 4 | 9733766 | ||
| Pubmed | 1.62e-08 | 9 | 119 | 4 | 28877029 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | PMS1 EHBP1 NUP50 ZC3H14 EPS15 SYNRG RANBP2 HAUS6 ANK2 EP400 ZNF280C XIAP ATF7IP SEC23IP SMCR8 NOP2 PRRC2B | 2.14e-08 | 934 | 119 | 17 | 33916271 |
| Pubmed | 2.69e-08 | 10 | 119 | 4 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 2.69e-08 | 10 | 119 | 4 | 16332688 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 2.69e-08 | 10 | 119 | 4 | 8857542 | |
| Pubmed | 2.69e-08 | 10 | 119 | 4 | 22969705 | ||
| Pubmed | 2.69e-08 | 10 | 119 | 4 | 21859863 | ||
| Pubmed | AKAP6 SLAIN2 EP400 ZNF280C PHRF1 ADGRV1 SIK3 BCR BAP1 CAPRIN2 TNRC6A SCAF11 NUP188 | 3.63e-08 | 529 | 119 | 13 | 14621295 | |
| Pubmed | 4.22e-08 | 11 | 119 | 4 | 17069463 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 4.22e-08 | 11 | 119 | 4 | 35771867 | |
| Pubmed | 4.22e-08 | 11 | 119 | 4 | 34110283 | ||
| Pubmed | 4.70e-08 | 209 | 119 | 9 | 36779422 | ||
| Pubmed | SLAIN2 IL12RB2 EP400 PHRF1 XIAP CHEK1 SIK3 BCR ZNF518A SETDB2 MLH3 ZFHX4 CAPRIN2 TNRC6A CEP295 BICRAL NUP188 PRRC2B | 4.94e-08 | 1116 | 119 | 18 | 31753913 | |
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 9.10e-08 | 13 | 119 | 4 | 31427429 | |
| Pubmed | 1.73e-07 | 15 | 119 | 4 | 14697343 | ||
| Pubmed | AKAP6 PRAMEF7 MIA3 ZC3H13 APC XIAP PRAMEF8 ASH2L VCAN OTUD4 CEP295 ASXL2 ANKRD12 NUP188 QSER1 PEAK1 NPAT | 1.80e-07 | 1084 | 119 | 17 | 11544199 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | SLAIN2 SYNRG RANBP2 HAUS6 MIA3 RGPD1 APC XIAP SIK3 BCR NSFL1C TNRC6A DNAJC12 CEP295 PRRC2B | 2.40e-07 | 853 | 119 | 15 | 28718761 |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 2.50e-07 | 184 | 119 | 8 | 32908313 | |
| Pubmed | SLAIN2 ZC3H14 SYNRG HAUS6 EP400 MPDZ ASH2L JMJD1C SEC23IP QSER1 PEAK1 PRRC2B | 4.36e-07 | 549 | 119 | 12 | 38280479 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 7.52e-07 | 146 | 119 | 7 | 23892456 | |
| Pubmed | 9.09e-07 | 22 | 119 | 4 | 27717094 | ||
| Pubmed | EHBP1 EPS15 RANBP2 HAUS6 ANK2 APC MPDZ JMJD1C NSFL1C FANCI SEC23IP PEAK1 SMCR8 | 1.00e-06 | 708 | 119 | 13 | 39231216 | |
| Pubmed | SLAIN2 NUP50 ZC3H14 SP4 RANBP2 EP400 CHEK1 JMJD1C NSFL1C FANCI BICRAL ASXL2 QSER1 NOP2 PRRC2B MYB | 1.19e-06 | 1103 | 119 | 16 | 34189442 | |
| Pubmed | 1.22e-06 | 99 | 119 | 6 | 27746211 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 1.35e-06 | 7 | 119 | 3 | 15710750 | |
| Pubmed | Identification of novel cadherins expressed in human melanoma cells. | 1.35e-06 | 7 | 119 | 3 | 9182820 | |
| Pubmed | EPS15 MIA3 EP400 SYTL2 APC MPDZ BCR JMJD1C NSFL1C SEC23IP TNRC6A CEP295 QSER1 | 1.47e-06 | 733 | 119 | 13 | 34672954 | |
| Pubmed | EP400 RGPD1 SSBP2 ASH2L JMJD1C BAP1 ZFHX4 ATF7IP TNRC6A ZNF611 OTUD4 SCAF11 ASXL2 QSER1 NOP2 PRRC2B MYB NPAT | 1.80e-06 | 1429 | 119 | 18 | 35140242 | |
| Pubmed | Epigenetic functions of smchd1 repress gene clusters on the inactive X chromosome and on autosomes. | 1.86e-06 | 59 | 119 | 5 | 23754746 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | SLAIN2 NUP50 RGPD2 EPS15 RANBP2 HAUS6 RGPD1 APC CHEK1 BAP1 RGPD3 ASXL2 NUP188 NOP2 PRRC2B MYBL1 | 2.15e-06 | 1155 | 119 | 16 | 20360068 |
| Pubmed | Interaction network of human early embryonic transcription factors. | 3.58e-06 | 351 | 119 | 9 | 38297188 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PMS1 NUP50 ZC3H14 RANBP2 EP400 ZC3H13 ZNF280C JMJD1C FANCI ATF7IP SCAF11 QSER1 NOP2 NPAT | 5.10e-06 | 954 | 119 | 14 | 36373674 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 6.26e-06 | 283 | 119 | 8 | 30585729 | |
| Pubmed | 6.32e-06 | 11 | 119 | 3 | 15758025 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ZC3H14 SYNRG RANBP2 HAUS6 APC BCR CDC42BPB NSFL1C TNRC6A OTUD4 NOP2 PRRC2B | 7.54e-06 | 724 | 119 | 12 | 36232890 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | PMS1 ZNF280C WRN JMJD1C BAP1 SETDB2 FANCI SCAF11 QSER1 NOP2 NPAT | 8.17e-06 | 608 | 119 | 11 | 36089195 |
| Pubmed | EHBP1 RGPD2 SYNRG RANBP2 MIA3 ANK2 RGPD1 APC GRIA3 BCR CDC42BPB NSFL1C RGPD3 TNRC6A PEAK1 | 8.39e-06 | 1139 | 119 | 15 | 36417873 | |
| Pubmed | AKAP6 SLAIN2 NRIP1 RANBP2 ANK2 CMYA5 CDC42BPB ASH2L JMJD1C TAX1BP1 | 8.60e-06 | 497 | 119 | 10 | 23414517 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NUP50 ZC3H14 RANBP2 EP400 ZC3H13 PHRF1 WRN ASH2L JMJD1C BAP1 RGPD3 SCAF11 ASXL2 NUP188 QSER1 NOP2 | 9.02e-06 | 1294 | 119 | 16 | 30804502 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 9.82e-06 | 398 | 119 | 9 | 35016035 | |
| Pubmed | Loss of the tumor suppressor BAP1 causes myeloid transformation. | 1.09e-05 | 13 | 119 | 3 | 22878500 | |
| Pubmed | 1.09e-05 | 13 | 119 | 3 | 16510874 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 21190594 | ||
| Pubmed | Pediatric-type diffuse low-grade glioma with MYB/MYBL1 alteration: report of 2 cases. | 1.16e-05 | 2 | 119 | 2 | 36074655 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 35605119 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 32005247 | ||
| Pubmed | DNA binding and transactivation activity of A-myb, a c-myb-related gene. | 1.16e-05 | 2 | 119 | 2 | 7987850 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 31563982 | ||
| Pubmed | Genetic alterations in members of the Wnt pathway in acute leukemia. | 1.16e-05 | 2 | 119 | 2 | 21902576 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 19609274 | ||
| Pubmed | Structural basis of the Axin-adenomatous polyposis coli interaction. | 1.16e-05 | 2 | 119 | 2 | 10811618 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 8570177 | ||
| Pubmed | A single-center study of the clinicopathologic correlates of gliomas with a MYB or MYBL1 alteration. | 1.16e-05 | 2 | 119 | 2 | 31595312 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 31028361 | ||
| Pubmed | Osteopontin Deficiency Suppresses Intestinal Tumor Development in Apc-Deficient Min Mice. | 1.16e-05 | 2 | 119 | 2 | 28505114 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 35177477 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 29410490 | ||
| Interaction | PHF21A interactions | EHBP1 EPS15 RANBP2 HAUS6 APC BCR JMJD1C BAP1 ZFHX4 SEC23IP TNRC6A NPAT | 8.27e-07 | 343 | 118 | 12 | int:PHF21A |
| Interaction | NUP43 interactions | NUP50 RANBP2 EP400 ZC3H13 ZNF280C PHRF1 WRN APC CCDC168 JMJD1C ZNF518A FANCI ATF7IP ASXL2 NPAT | 3.78e-06 | 625 | 118 | 15 | int:NUP43 |
| Interaction | RGPD4 interactions | 7.53e-06 | 22 | 118 | 4 | int:RGPD4 | |
| Interaction | RNF43 interactions | EHBP1 RANBP2 HAUS6 MIA3 APC JMJD1C AXIN1 SEC23IP TNRC6A NUP188 PEAK1 PRRC2B | 7.90e-06 | 427 | 118 | 12 | int:RNF43 |
| Interaction | KDM1A interactions | EHBP1 NRIP1 EPS15 RANBP2 HAUS6 EP400 ZNF280C APC CHEK1 BCR JMJD1C BAP1 NSFL1C ZFHX4 ATF7IP SEC23IP TNRC6A NPAT | 9.01e-06 | 941 | 118 | 18 | int:KDM1A |
| Interaction | AP2B1 interactions | SLAIN2 NUP50 EPS15 SYNRG RGPD1 APC BCR BAP1 NSFL1C TNRC6A HEATR5B | 1.23e-05 | 373 | 118 | 11 | int:AP2B1 |
| Interaction | KCNA3 interactions | EHBP1 NRIP1 EPS15 RANBP2 HAUS6 AFF2 ANK2 SYTL2 APC MPDZ JMJD1C NSFL1C FANCI SEC23IP CAPRIN2 PEAK1 SMCR8 | 1.27e-05 | 871 | 118 | 17 | int:KCNA3 |
| Interaction | RGPD2 interactions | 1.77e-05 | 27 | 118 | 4 | int:RGPD2 | |
| Interaction | CEP135 interactions | 3.23e-05 | 272 | 118 | 9 | int:CEP135 | |
| Interaction | WWTR1 interactions | SLAIN2 SYNRG HAUS6 EP400 MPDZ ASH2L JMJD1C SEC23IP QSER1 PEAK1 PRRC2B | 3.83e-05 | 422 | 118 | 11 | int:WWTR1 |
| Interaction | NAA40 interactions | PMS1 EHBP1 NUP50 ZC3H14 EPS15 SYNRG RANBP2 HAUS6 ANK2 EP400 ZNF280C XIAP ATF7IP SEC23IP SMCR8 NOP2 PRRC2B | 5.49e-05 | 978 | 118 | 17 | int:NAA40 |
| Interaction | CNOT9 interactions | 6.54e-05 | 231 | 118 | 8 | int:CNOT9 | |
| Interaction | PCDHB12 interactions | 6.80e-05 | 14 | 118 | 3 | int:PCDHB12 | |
| Interaction | RGPD8 interactions | 7.38e-05 | 74 | 118 | 5 | int:RGPD8 | |
| Interaction | HDAC1 interactions | EHBP1 NUP50 NRIP1 EPS15 RANBP2 HAUS6 EP400 WRN APC BCR ASH2L JMJD1C BAP1 ZFHX4 TAX1BP1 SEC23IP TNRC6A NPAT | 7.76e-05 | 1108 | 118 | 18 | int:HDAC1 |
| Interaction | PML interactions | PMS1 SLAIN2 NUP50 EPS15 SYNRG RANBP2 EP400 WRN XIAP JMJD1C AXIN1 ATF7IP RGPD3 NOP2 MYB RNF111 | 1.09e-04 | 933 | 118 | 16 | int:PML |
| Interaction | FHL2 interactions | 1.13e-04 | 396 | 118 | 10 | int:FHL2 | |
| Interaction | HNF1B interactions | 1.29e-04 | 190 | 118 | 7 | int:HNF1B | |
| Interaction | SLX4 interactions | PMS1 NUP50 RANBP2 EP400 WRN ZNF518A MLH3 FANCI ATF7IP RGPD3 NUP188 PRRC2B | 1.35e-04 | 572 | 118 | 12 | int:SLX4 |
| Interaction | UBXN2B interactions | 1.38e-04 | 45 | 118 | 4 | int:UBXN2B | |
| Interaction | RGPD3 interactions | 1.64e-04 | 47 | 118 | 4 | int:RGPD3 | |
| Interaction | CBR1 interactions | 1.90e-04 | 142 | 118 | 6 | int:CBR1 | |
| Interaction | RGPD1 interactions | 1.93e-04 | 49 | 118 | 4 | int:RGPD1 | |
| Interaction | TRIM66 interactions | 2.07e-04 | 205 | 118 | 7 | int:TRIM66 | |
| Cytoband | 5q31 | PCDHB15 PCDHB14 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB16 | 7.53e-10 | 115 | 119 | 8 | 5q31 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | MEIKIN PCDHB15 PCDHB14 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB16 | 9.39e-08 | 298 | 119 | 9 | chr5q31 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q14 | 4.49e-04 | 136 | 119 | 4 | chr5q14 | |
| GeneFamily | Clustered protocadherins | PCDHB15 PCDHB14 PCDHB12 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB16 | 8.07e-10 | 64 | 88 | 8 | 20 |
| GeneFamily | MutL homologs | 1.40e-04 | 4 | 88 | 2 | 1027 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.54e-04 | 181 | 88 | 6 | 694 | |
| GeneFamily | Nucleoporins | 4.99e-04 | 32 | 88 | 3 | 1051 | |
| GeneFamily | ATP binding cassette subfamily C | 1.76e-03 | 13 | 88 | 2 | 807 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 2.19e-03 | 53 | 88 | 3 | 532 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.40e-03 | 115 | 88 | 4 | 769 | |
| Coexpression | MIKKELSEN_ES_HCP_WITH_H3K27ME3 | 3.54e-08 | 42 | 119 | 6 | MM1275 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 3.80e-07 | 33 | 119 | 5 | MM477 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | AKAP6 SP4 MIA3 AFF2 ANK2 SYTL2 APC SIK3 NDST3 ZFHX4 VCAN CAPRIN2 TNRC6A SCN9A OTUD4 DNAJC12 ANKRD12 SPAG17 PRRC2B | 5.84e-07 | 1106 | 119 | 19 | M39071 |
| Coexpression | MIKKELSEN_ES_HCP_WITH_H3K27ME3 | 1.17e-06 | 41 | 119 | 5 | M2000 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PMS1 EHBP1 UBR2 ZC3H14 NRIP1 EPS15 RANBP2 WRN APC TOGARAM1 SSBP2 SIK3 OTUD4 BICRAL MYBL1 NPAT | 1.70e-06 | 856 | 119 | 16 | M4500 |
| Coexpression | MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED | 4.26e-06 | 93 | 119 | 6 | MM1266 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | NRIP1 HAUS6 SPP1 WRN APC DMXL1 ATF7IP TAX1BP1 CAPRIN2 ZNF611 SCAF11 QSER1 MYBL1 | 9.24e-06 | 656 | 119 | 13 | M18979 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 9.62e-06 | 300 | 119 | 9 | M8702 | |
| Coexpression | MULLIGHAN_MLL_SIGNATURE_2_DN | 4.22e-05 | 279 | 119 | 8 | M16867 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 4.35e-05 | 43 | 119 | 4 | MM3857 | |
| Coexpression | GSE21033_1H_VS_12H_POLYIC_STIM_DC_DN | 4.59e-05 | 141 | 119 | 6 | M7720 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | UBR2 NUP50 HAUS6 WRN XIAP SIK3 JMJD1C AXIN1 CGRRF1 ATF7IP RIPOR1 ANKRD12 PRRC2B | 9.46e-05 | 822 | 119 | 13 | M6782 |
| Coexpression | MULLIGHAN_MLL_SIGNATURE_1_DN | 1.10e-04 | 238 | 119 | 7 | M18841 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | VIL1 NRIP1 EPS15 ZC3H13 PCDHB9 SSBP2 CHEK1 DMXL1 ZNF518A CAPRIN2 TNRC6A SCAF11 CEP295 ASXL2 ANKRD12 PEAK1 MYBL1 | 1.42e-06 | 778 | 118 | 17 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | NRIP1 EPS15 SP4 SPP1 ZC3H13 PCDHB11 PCDHB9 GRIA3 SSBP2 CHEK1 JMJD1C DMXL1 TNRC6A SCAF11 CEP295 ANKRD12 MYBL1 | 2.11e-06 | 801 | 118 | 17 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | NRIP1 EPS15 ZC3H13 SSBP2 CHEK1 JMJD1C DMXL1 CEP295 ANKRD12 MYBL1 | 3.21e-06 | 275 | 118 | 10 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | EPS15 HAUS6 ZC3H13 APC XIAP TOGARAM1 JMJD1C TAX1BP1 RIPOR1 ASXL2 QSER1 HEATR5B NPAT | 1.55e-05 | 564 | 118 | 13 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | SLAIN2 HAUS6 ZNF280C PCDHB15 PCDHB12 PCDHB11 PCDHB10 XIAP TOGARAM1 SSBP2 CHEK1 PCDHB16 ZNF518A ZFHX4 VCAN ASXL2 | 1.58e-05 | 836 | 118 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | SLAIN2 HAUS6 ZNF280C PCDHB15 PCDHB11 TOGARAM1 SSBP2 CHEK1 PCDHB16 ZNF518A VCAN ASXL2 | 1.93e-05 | 492 | 118 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.31e-05 | 210 | 118 | 8 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | NRIP1 EPS15 SP4 ZC3H13 SSBP2 CHEK1 JMJD1C DMXL1 ZNF518A SETDB2 CEP295 ASXL2 ANKRD12 MYBL1 NPAT | 2.65e-05 | 776 | 118 | 15 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500 | AKAP6 NPY2R PCDHB12 PCDHB11 WRN APC XIAP ZFHX4 VCAN OTUD4 ASXL2 | 2.66e-05 | 427 | 118 | 11 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | NRIP1 ZC3H13 PCDHB12 PCDHB11 PCDHB9 GRIA3 SSBP2 CHEK1 JMJD1C DMXL1 TNRC6A SCAF11 CEP295 ANKRD12 MYBL1 | 3.25e-05 | 790 | 118 | 15 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_200 | 3.29e-05 | 161 | 118 | 7 | gudmap_developingGonad_e11.5_ovary + mesonephros_200 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_500 | 3.57e-05 | 67 | 118 | 5 | gudmap_developingGonad_e18.5_epididymis_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.28e-05 | 229 | 118 | 8 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | AKAP6 NPY2R ANK2 PCDHB12 PCDHB11 WRN PCDHB7 APC XIAP SSBP2 CHEK1 ZFHX4 VCAN OTUD4 ASXL2 | 4.84e-05 | 818 | 118 | 15 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500 | EPS15 ZC3H13 SSBP2 CHEK1 DMXL1 ZNF518A SETDB2 CEP295 ANKRD12 MYBL1 | 5.49e-05 | 382 | 118 | 10 | gudmap_developingGonad_e14.5_ ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | NRIP1 EPS15 ZC3H13 PCDHB9 GRIA3 SSBP2 DMXL1 SCAF11 CEP295 MYBL1 | 8.73e-05 | 404 | 118 | 10 | gudmap_developingGonad_e18.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | NRIP1 SPP1 ZC3H13 PCDHB11 PCDHB9 GRIA3 SSBP2 DMXL1 SCAF11 CEP295 | 1.05e-04 | 413 | 118 | 10 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_500 | 1.39e-04 | 89 | 118 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | NRIP1 EPS15 ZC3H13 PCDHB11 PCDHB9 GRIA3 SSBP2 JMJD1C DMXL1 TNRC6A SCAF11 CEP295 ANKRD12 MYBL1 | 1.42e-04 | 799 | 118 | 14 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | NRIP1 EPS15 ZC3H13 SSBP2 CHEK1 JMJD1C DMXL1 MMRN1 ZFHX4 SCAF11 CEP295 ASXL2 ANKRD12 MYBL1 | 1.51e-04 | 804 | 118 | 14 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_500 | 2.52e-04 | 101 | 118 | 5 | gudmap_developingGonad_e14.5_ ovary_500_k1 | |
| CoexpressionAtlas | PP_RBC_top-relative-expression-ranked_2500_k-means-cluster#3 | 2.56e-04 | 158 | 118 | 6 | PP_RBC_2500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_200 | 2.65e-04 | 159 | 118 | 6 | gudmap_developingGonad_e12.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | HAUS6 ANK2 ZNF280C PCDHB15 PCDHB12 PCDHB11 PCDHB10 SSBP2 PCDHB16 ZFHX4 ATF7IP VCAN ASXL2 MYB | 2.68e-04 | 850 | 118 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| CoexpressionAtlas | kidney_e13.5_Podocyte_MafB_k-means-cluster#4_top-relative-expression-ranked_200 | 2.73e-04 | 23 | 118 | 3 | gudmap_kidney_e13.5_Podocyte_MafB_k4_200 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.04e-04 | 230 | 118 | 7 | gudmap_developingGonad_e18.5_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_500 | 3.23e-04 | 165 | 118 | 6 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | HAUS6 ZNF280C PCDHB15 PCDHB11 SSBP2 ZFHX4 ATF7IP VCAN ASXL2 MYB | 3.39e-04 | 478 | 118 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k5 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_500 | 3.59e-04 | 109 | 118 | 5 | gudmap_developingGonad_e16.5_ovary_500_k5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_200 | 3.70e-04 | 61 | 118 | 4 | gudmap_developingGonad_e12.5_epididymis_k2_200 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 4.03e-04 | 172 | 118 | 6 | gudmap_developingGonad_e11.5_ovary + mesonephros_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#2_top-relative-expression-ranked_200 | 4.72e-04 | 65 | 118 | 4 | gudmap_developingGonad_e12.5_ovary_k2_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#3_top-relative-expression-ranked_500 | 4.90e-04 | 249 | 118 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | 5.41e-04 | 417 | 118 | 9 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_200 | 5.93e-04 | 69 | 118 | 4 | gudmap_developingGonad_e11.5_ovary + mesonephros_k5_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | PMS1 CHEK1 DMXL1 ZNF518A SETDB2 FANCI CAPRIN2 OTUD4 CEP295 ANKRD12 NUP188 MYBL1 NPAT | 6.41e-04 | 820 | 118 | 13 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_1000 | AKAP6 HAUS6 MAGEL2 NPY2R ANK2 PCDHB15 PCDHB12 PCDHB11 PCDHB10 PCDHB7 SSBP2 PCDHB16 ZFHX4 | 6.93e-04 | 827 | 118 | 13 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 6.96e-04 | 432 | 118 | 9 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-08 | 176 | 119 | 8 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 6.99e-07 | 186 | 119 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.64e-07 | 192 | 119 | 7 | d43caf42ec744e895137f31ef65a990e250669d2 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 8.95e-07 | 193 | 119 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.10e-06 | 199 | 119 | 7 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 1.95e-06 | 138 | 119 | 6 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.10e-06 | 163 | 119 | 6 | 132aece9c79499b4bb3c2bde68d3d7202e1d8772 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.67e-06 | 166 | 119 | 6 | 7286a37b2827f3747469ffd0d76cbe81116db7ee | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.67e-06 | 166 | 119 | 6 | 7c2eee0a4f45795a956acf936b85bdb35f1b1624 | |
| ToppCell | facs-Lung-EPCAM-18m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-06 | 170 | 119 | 6 | 12203d4410f38cc933d9f160b5fb76828df94119 | |
| ToppCell | facs-Lung-EPCAM-18m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-06 | 170 | 119 | 6 | f9decb3bf3bf6d4996b0ac27af768236e116aac5 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.59e-06 | 182 | 119 | 6 | 53c267ee327e116dbd89d5927ed3bdf78d25ee62 | |
| ToppCell | hematopoetic_progenitors-CD34+_HSC|World / Lineage and Cell class | 1.19e-05 | 189 | 119 | 6 | 51ff31c9cf5eff98ad01c0455dc4ae4908713575 | |
| ToppCell | ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.22e-05 | 190 | 119 | 6 | 9ce301841ce9486701fa28eb2a9929e35d476878 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-05 | 190 | 119 | 6 | 96a92212ea3fb35fa3d0da495e504edc61c71c23 | |
| ToppCell | facs-Marrow-KLS-18m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-05 | 194 | 119 | 6 | c9ebdcc2ea600975dade68a41fa65d1f8a5a5926 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-05 | 195 | 119 | 6 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.55e-05 | 198 | 119 | 6 | 93cc01d91ffc543fd1a717ef47e02e532b50b665 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.55e-05 | 198 | 119 | 6 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 1.59e-05 | 199 | 119 | 6 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | COVID-19-COVID-19_Severe-Others-HSPC|COVID-19_Severe / Disease, condition lineage and cell class | 1.59e-05 | 199 | 119 | 6 | 25de67b6c9c8d6bb9a538e071a40ef865906c95d | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.59e-05 | 199 | 119 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.64e-05 | 200 | 119 | 6 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.13e-05 | 135 | 119 | 5 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-05 | 137 | 119 | 5 | e9b88ad86b75454a8292a94879c5b665adc42744 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.02e-05 | 149 | 119 | 5 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.18e-05 | 150 | 119 | 5 | 6785b695a01de47a47f5c94fdc432428ef80bada | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.18e-05 | 150 | 119 | 5 | ddfb7dd696f06e834c45d6c3f9b1138bc17d62b3 | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.06e-05 | 155 | 119 | 5 | b5d5c38b269e9318970fcce564df1c8ed7a7ccc6 | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-SC_&_Eosinophil|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.63e-05 | 158 | 119 | 5 | 0d4fe87fc7901dd5f9c004e91708a03cafdb4ad9 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-05 | 158 | 119 | 5 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-05 | 158 | 119 | 5 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage-pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.04e-05 | 160 | 119 | 5 | 30b7f24e0c3ecfa618b4e31678e18c8a4405a8d7 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.37e-05 | 166 | 119 | 5 | ceb0a48c0d853448fd45ac31dde046df9a178571 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.86e-05 | 168 | 119 | 5 | 74dc46738f1d0a448df6c9b8288b515d92697792 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.90e-05 | 172 | 119 | 5 | 1bad7b19724e1b53ace7e05644215334c9f43910 | |
| ToppCell | COPD-Lymphoid-ILC_A|Lymphoid / Disease state, Lineage and Cell class | 1.02e-04 | 173 | 119 | 5 | 4a0043b29f8ede5a74bdb38cbf2c70e12b25e130 | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells-Lymphatic_ECs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.04e-04 | 174 | 119 | 5 | d551bc29afef071adf4c9bb80345352ec33441d8 | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-HSC-MPP|lymph-node_spleen / Manually curated celltypes from each tissue | 1.10e-04 | 176 | 119 | 5 | 32ed5623b8809b9f1aaf7a42dff9807d9376e9c2 | |
| ToppCell | Ciliated_cells-A-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.10e-04 | 176 | 119 | 5 | 1c364155f46b9a7c995bdc2cc2333c437cd90f5b | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-04 | 178 | 119 | 5 | 5289ac61637224ae70ffbc2d164d73116f10af40 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-04 | 178 | 119 | 5 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-04 | 179 | 119 | 5 | 8ce5000088b727783a0619baa16a2cd036d21f54 | |
| ToppCell | ILEUM-non-inflamed-(7)_Lymphatics|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.19e-04 | 179 | 119 | 5 | 99777a8931356d1206b8ab22aaa1b1d5a600b809 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Dendritic_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 180 | 119 | 5 | 5b7d2336ed09d07f6b8dd91c1fa9c5ade633c104 | |
| ToppCell | COVID-19_Severe-Hematopoietic_SC-HSPC|COVID-19_Severe / Disease group, lineage and cell class | 1.32e-04 | 183 | 119 | 5 | 4146b1c0e5f76d25226745abfa28f77127a444fc | |
| ToppCell | COVID-19_Severe-Hematopoietic_SC|COVID-19_Severe / Disease group, lineage and cell class | 1.32e-04 | 183 | 119 | 5 | 92aab7ce65aca17988bc2add4ff9fb8384e2c21b | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.36e-04 | 184 | 119 | 5 | a6169613c6493b947a176493f542368bfa935dab | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.36e-04 | 184 | 119 | 5 | 51d0447699e3b8f01abbde83f26b748bc9f3c723 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 184 | 119 | 5 | fea4fe648e9749177d0783443dc26a7df5807883 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.36e-04 | 184 | 119 | 5 | f7b0bb45a9055ab34e98b251217f6ec38c75ca22 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 184 | 119 | 5 | 96a8a0a190bc293655fe7d80cbed8119c0da25f2 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 184 | 119 | 5 | 780eb72da43527f0c72effac3423ec7384f05f20 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.36e-04 | 184 | 119 | 5 | cc01c19180861f491a8dc16d60fabd1215fc4525 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.36e-04 | 184 | 119 | 5 | 492c680f0769ba4e651d09c2e8e5d5d271ed08aa | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.36e-04 | 184 | 119 | 5 | 26edbf84216538b80f1ffcc079ee6e385a71fbf9 | |
| ToppCell | ILEUM-inflamed-(7)_Lymphatics|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.39e-04 | 185 | 119 | 5 | d711dd2e91cfee723dae1ccb2b910b8cf3becc3b | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 187 | 119 | 5 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells-Tumor_ECs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.46e-04 | 187 | 119 | 5 | 2713f526f86911fbbf6c7a3e69230f2e6bde31c3 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.50e-04 | 188 | 119 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-SC_&_Eosinophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.54e-04 | 189 | 119 | 5 | 2157a2d40613f7d5ce2e7dbd266df441e449cdaf | |
| ToppCell | COVID-19_Severe-HSPC|COVID-19_Severe / disease group, cell group and cell class | 1.54e-04 | 189 | 119 | 5 | 96015439971e2e5b8d6294ca5a6b873c7774e925 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.58e-04 | 190 | 119 | 5 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.58e-04 | 190 | 119 | 5 | 3f0c7d130f66faea778fe567604edf1b4cdf85b3 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.62e-04 | 191 | 119 | 5 | 40813c397f533c2f4a6359a77757f736b6d9e07d | |
| ToppCell | B_cell_maturation-CD34+_pre-plamsa|B_cell_maturation / Lineage and Cell class | 1.62e-04 | 191 | 119 | 5 | 4ee160a863d4fb9c4c9449633b9f337db8871992 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.62e-04 | 191 | 119 | 5 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 191 | 119 | 5 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.65e-04 | 192 | 119 | 5 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-04 | 192 | 119 | 5 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.65e-04 | 192 | 119 | 5 | c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.70e-04 | 193 | 119 | 5 | 544de0988510cc57744710d7cafe07aa27a0b99d | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 193 | 119 | 5 | a6a864644e1b80b7417ea0a27281e79068a3fd3d | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.70e-04 | 193 | 119 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | COVID-19_Mild-PLT_4|World / Disease Group and Platelet Clusters | 1.70e-04 | 193 | 119 | 5 | 98a52523aa1efd5d14a2878ed106828a80a33aa2 | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 194 | 119 | 5 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.74e-04 | 194 | 119 | 5 | f64da5f62e29253d60b9546edf734ba5c17daae1 | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 194 | 119 | 5 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 194 | 119 | 5 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.78e-04 | 195 | 119 | 5 | 23ab7e2a419377c05bab0e92a2457afbcd3d9e07 | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.91e-04 | 198 | 119 | 5 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | COVID-19_Mild-PLT_4|COVID-19_Mild / Disease Group and Platelet Clusters | 1.91e-04 | 198 | 119 | 5 | 3d8c33dba759df0974aeb2b9a6b5167ae7a18e1f | |
| ToppCell | control-Platelet|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.91e-04 | 198 | 119 | 5 | 1a4b604ef25bd066e870c0d00ee31cde9617f125 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.95e-04 | 199 | 119 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | MS-IIF-Others-HSPC|IIF / Disease, condition lineage and cell class | 1.95e-04 | 199 | 119 | 5 | 3384db80f6024bcabe2625f24d5f4e0d3d8caa7e | |
| ToppCell | Control-Control-Others-HSPC|Control / Disease, condition lineage and cell class | 1.95e-04 | 199 | 119 | 5 | b71169be0d916b2ed139a3122d78bb154c71edb4 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.95e-04 | 199 | 119 | 5 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.95e-04 | 199 | 119 | 5 | 47466253069d4b1b8f13ce3210f434e60753b38a | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 1.95e-04 | 199 | 119 | 5 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 2.00e-04 | 200 | 119 | 5 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.00e-04 | 200 | 119 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | MS-Multiple_Sclerosis-Others-Platelet|Multiple_Sclerosis / Disease, condition lineage and cell class | 2.00e-04 | 200 | 119 | 5 | 263d956136747c209951b4358f2e1672a21d8eef | |
| ToppCell | mild-NK_CD56bright|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.00e-04 | 200 | 119 | 5 | a195bc6784346f706d4cd5b740adac1d950ce88a | |
| ToppCell | Control-Control-Others-Platelet|Control / Disease, condition lineage and cell class | 2.00e-04 | 200 | 119 | 5 | e0463c93714ab5fd00f294cca83bd61027fe0e95 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-OPC_related-Oligodendrocyte/OPC|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 2.00e-04 | 200 | 119 | 5 | 4db894cfb80fd1f9e01133f345eefd78edd4bc43 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-OPC_related|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 2.00e-04 | 200 | 119 | 5 | d46a19274c2836ce7494790ce513764dedcadc79 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.40e-04 | 113 | 119 | 4 | b795a0c65114b3c0758fe3720e8a80247f900971 | |
| Drug | AC1MF7BR | 3.17e-06 | 44 | 118 | 5 | CID002867154 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 3.55e-06 | 174 | 118 | 8 | 7530_DN | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 4.94e-06 | 182 | 118 | 8 | 3630_DN | |
| Drug | Succimer | PMS1 NRIP1 EPS15 HAUS6 MIA3 SPP1 ZC3H13 ZBTB8A CHEK1 SIK3 ITGAX JMJD1C ZNF518A ZFHX4 ZNF296 OTUD4 ANKRD12 QSER1 ABCC2 MYB | 7.45e-06 | 1264 | 118 | 20 | ctd:D004113 |
| Disease | Glioma | 1.99e-05 | 87 | 111 | 5 | C0017638 | |
| Disease | Adenocarcinoma of large intestine | 3.20e-05 | 96 | 111 | 5 | C1319315 | |
| Disease | Central Nervous System Neoplasms | 8.37e-05 | 4 | 111 | 2 | C0085136 | |
| Disease | Malignant Glioma | 1.44e-04 | 70 | 111 | 4 | C0555198 | |
| Disease | mixed gliomas | 1.44e-04 | 70 | 111 | 4 | C0259783 | |
| Disease | Endometrial Carcinoma | 1.60e-04 | 72 | 111 | 4 | C0476089 | |
| Disease | Hereditary Nonpolyposis Colorectal Cancer | 1.76e-04 | 29 | 111 | 3 | C1333990 | |
| Disease | intellectual disability (implicated_via_orthology) | 1.88e-04 | 75 | 111 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | Hepatoblastoma | 2.08e-04 | 6 | 111 | 2 | C0206624 | |
| Disease | Tumor of Rete Testis | 2.08e-04 | 6 | 111 | 2 | C1720811 | |
| Disease | vitamin D measurement | 2.88e-04 | 336 | 111 | 7 | EFO_0004631 | |
| Disease | Malignant neoplasm of testis | 2.91e-04 | 7 | 111 | 2 | C0153594 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 3.87e-04 | 8 | 111 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 3.87e-04 | 8 | 111 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 3.87e-04 | 8 | 111 | 2 | C0338479 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 3.87e-04 | 8 | 111 | 2 | C0751120 | |
| Disease | Myoclonic Encephalopathy | 3.87e-04 | 8 | 111 | 2 | C0438414 | |
| Disease | Testicular Neoplasms | 3.87e-04 | 8 | 111 | 2 | C0039590 | |
| Disease | Myoclonic Absence Epilepsy | 3.87e-04 | 8 | 111 | 2 | C0393703 | |
| Disease | HEPATOCELLULAR CARCINOMA | 4.96e-04 | 9 | 111 | 2 | 114550 | |
| Disease | Lynch Syndrome | 4.96e-04 | 9 | 111 | 2 | C4552100 | |
| Disease | Hepatocellular carcinoma | 4.96e-04 | 9 | 111 | 2 | cv:C2239176 | |
| Disease | Myoclonic Epilepsy | 4.96e-04 | 9 | 111 | 2 | C0014550 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 4.96e-04 | 9 | 111 | 2 | C3502809 | |
| Disease | Mesothelioma | 4.98e-04 | 41 | 111 | 3 | C0025500 | |
| Disease | obsolete_red blood cell distribution width | EHBP1 NRIP1 EP400 RGPD1 SIK3 ITGAX F8 AXIN1 FANCI ZNF611 ASXL2 ANKRD12 SMCR8 MYB | 5.36e-04 | 1347 | 111 | 14 | EFO_0005192 |
| Disease | Adenoid Cystic Carcinoma | 5.63e-04 | 100 | 111 | 4 | C0010606 | |
| Disease | Epilepsy, Myoclonic, Infantile | 6.19e-04 | 10 | 111 | 2 | C0917800 | |
| Disease | Malignant neoplasm of breast | AKAP6 EHBP1 NRIP1 ANK2 SPP1 PCDHB15 CHEK1 SIK3 BAP1 PPP1R3A TAX1BP1 ANKRD30A | 7.32e-04 | 1074 | 111 | 12 | C0006142 |
| Disease | Myoclonic Astatic Epilepsy | 7.54e-04 | 11 | 111 | 2 | C0393702 | |
| Disease | alcohol and nicotine codependence | 1.06e-03 | 13 | 111 | 2 | EFO_0004776 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 1.06e-03 | 13 | 111 | 2 | C0751122 | |
| Disease | level of Phosphatidylethanolamine (18:1_18:1) in blood serum | 1.24e-03 | 14 | 111 | 2 | OBA_2045142 | |
| Disease | cortical surface area measurement | SP4 ZC3H13 RGPD1 APC RCSD1 SSBP2 ADGRV1 BCR AXIN1 VCAN TNRC6A QSER1 SPAG17 | 1.64e-03 | 1345 | 111 | 13 | EFO_0010736 |
| Disease | ovarian neoplasm | 1.67e-03 | 134 | 111 | 4 | C0919267 | |
| Disease | Malignant neoplasm of ovary | 1.81e-03 | 137 | 111 | 4 | C1140680 | |
| Disease | Malignant neoplasm of endometrium | 2.06e-03 | 18 | 111 | 2 | C0007103 | |
| Disease | Carcinoma in situ of endometrium | 2.06e-03 | 18 | 111 | 2 | C0346191 | |
| Disease | Meningioma | 2.30e-03 | 19 | 111 | 2 | C0025286 | |
| Disease | chronic myeloid leukemia (is_implicated_in) | 2.81e-03 | 21 | 111 | 2 | DOID:8552 (is_implicated_in) | |
| Disease | very low density lipoprotein cholesterol measurement | 3.07e-03 | 260 | 111 | 5 | EFO_0008317 | |
| Disease | cholangiocarcinoma (is_implicated_in) | 3.08e-03 | 22 | 111 | 2 | DOID:4947 (is_implicated_in) | |
| Disease | Splenomegaly | 3.08e-03 | 22 | 111 | 2 | C0038002 | |
| Disease | platelet crit | 3.19e-03 | 952 | 111 | 10 | EFO_0007985 | |
| Disease | interleukin 10 measurement | 3.21e-03 | 78 | 111 | 3 | EFO_0004750 | |
| Disease | level of Phosphatidylethanolamine (16:0_18:2) in blood serum | 3.67e-03 | 24 | 111 | 2 | OBA_2045136 | |
| Disease | Lynch syndrome (is_implicated_in) | 3.67e-03 | 24 | 111 | 2 | DOID:3883 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EAKAAAAPFQTSQAS | 1516 | Q96L91 | |
| NSPATEQTIFDSQTF | 2131 | P13611 | |
| SPVNSASSEENVKYS | 301 | O14757 | |
| ASSEENVKYSSSQPE | 306 | O14757 | |
| QPNFSTEESASETTQ | 796 | Q8IZF6 | |
| KSRSPSQNSQQSFDS | 366 | P11274 | |
| ESNPSAKEDSNPNSS | 211 | P51816 | |
| NEEKPSLNSVFTFTS | 3331 | Q8WXG9 | |
| ESSTKASANDQRFPS | 456 | Q9BXX3 | |
| AETNANVDNSASPSV | 6 | Q6JBY9 | |
| EKSVSPQNSDSSGFA | 156 | Q9UKB3 | |
| SQESQLPEESKSASN | 276 | Q92560 | |
| FTKPIQSENSDSDSN | 6 | Q6UB98 | |
| QNKSTVDVAFQDPSA | 686 | Q9Y485 | |
| STTRDPQAFNKAENT | 1381 | Q9Y485 | |
| NYNKSESQESLVTSP | 511 | Q76L83 | |
| PAYDNQKQSSAVSTS | 266 | Q9UBL3 | |
| ESNKVAAETQSPSLF | 211 | Q9UKX7 | |
| PSNVTTDFLFEKSAN | 656 | O95803 | |
| APLKSNNSETSSVAQ | 2551 | P49792 | |
| APQNAVSSEETNDFK | 56 | P10451 | |
| DEQAFPALSSSSVNQ | 466 | Q01804 | |
| NVQTQESSSPQSQKF | 501 | Q2KHR3 | |
| SSENNTPRTSKTTFQ | 901 | P20702 | |
| RKNSGPNDSFTEATN | 366 | P49146 | |
| STKQPSNDSASVELN | 631 | Q14207 | |
| AQASKSENSQEPSSS | 651 | Q14207 | |
| SENSQEPSSSVKEEN | 656 | Q14207 | |
| ESQNTDDKPSSNNSA | 716 | Q14207 | |
| VPSQSFFSSEESKTQ | 2931 | Q01484 | |
| SADFSQSTSIGIKNN | 726 | Q9NVI1 | |
| SQLKAENSSQEAQPS | 911 | Q5T3U5 | |
| NNKISAVPANAFDST | 531 | Q7Z5L7 | |
| STFQSEAEPQSKSQS | 411 | O43194 | |
| APQATATTQEASKTS | 861 | Q9UJ55 | |
| TDKITNFTTPTNANT | 2326 | Q2M2H8 | |
| VSDQKNAPAAESVSN | 526 | Q13201 | |
| EPKDSQANFKSSSEQ | 1256 | Q15652 | |
| AAQYKSSNASETEPN | 1491 | Q15652 | |
| SSNASETEPNAIKNQ | 1496 | Q15652 | |
| SPESNFTAKVTAVNS | 191 | Q99665 | |
| ERPANSSKNSTETAN | 306 | Q8NDZ0 | |
| VPFSDQQISNDSASS | 406 | P42263 | |
| PTSDSATQDNSFNKN | 936 | Q9UHC1 | |
| NYESPSSNNQDKDSS | 386 | Q9H792 | |
| PASQATAASNSEEKT | 1531 | Q9P1Y6 | |
| KSESDQPVSLDNFTQ | 451 | P48552 | |
| SSLQENSSNEFPANA | 316 | A0A087WXM9 | |
| ENNESSNNPSSIASF | 186 | Q92887 | |
| SKNNAIEPRSFSQNS | 751 | P00451 | |
| ESSKASQPAVATSFQ | 201 | P10242 | |
| FRTSSASEQETQAPK | 966 | Q9Y5S2 | |
| VSDVNDNAPAFTQTS | 441 | Q9UN67 | |
| VSDVNDNAPAFTQTS | 441 | Q9Y5E8 | |
| SSPAQQAENEAKASS | 271 | Q9UNZ2 | |
| SSPTASQNNSKAAVN | 401 | Q9UKI9 | |
| VSDVNDNAPAFTQTS | 441 | Q9Y5F1 | |
| VSDVNDNAPTFTQTS | 441 | Q9Y5F2 | |
| SVTSEENNFENPKNT | 266 | Q16821 | |
| SDTNVNKSASPTATA | 41 | Q96LP2 | |
| ISDVNDNAPTFTQTS | 441 | Q9NRJ7 | |
| LSDVNDNAPTFTQTS | 441 | Q9Y5E9 | |
| VSDVNDNAPAFTQTS | 441 | Q9Y5E2 | |
| APLKSNNSETSSVAQ | 1576 | A6NKT7 | |
| NTGDKESSSANVSPF | 1111 | Q9P2D3 | |
| NSIFANSSNADPKSS | 46 | Q6AI39 | |
| ALAPATSANDSEQQS | 311 | O15169 | |
| EQFSSSQKQKAETFP | 1056 | Q8N3K9 | |
| PVASKEQNLSSQSDF | 661 | Q6IMN6 | |
| VANSPSSAAQKAVTE | 961 | Q8NDI1 | |
| FSTSSAAEQNSNTTP | 916 | Q6VMQ6 | |
| NSPLSDVAKNTESSA | 506 | Q7Z4H7 | |
| SSSSSEANFKLEPNS | 791 | Q7Z4H7 | |
| KTTDQAPNTDASRSQ | 511 | Q9ULL0 | |
| SEKQDNFTQLASVPS | 1491 | Q9ULL0 | |
| SKVNNEDPFRSATSS | 731 | P42566 | |
| TTTTNKEADPSNFAN | 831 | P42566 | |
| FSQPNLQESSDTEKT | 4001 | Q8NDH2 | |
| FTPSNNSSSEEKNTD | 236 | Q99675 | |
| QESSPTKNNIAVSSD | 911 | Q9C0D2 | |
| ASFPEALSQKQTADN | 121 | Q5VWM4 | |
| NSNSSGSESFKFVEQ | 1106 | Q99590 | |
| PSTNSYENNKTDVSA | 341 | P54277 | |
| SAQQNSPTKFLAVEA | 331 | P10243 | |
| FVSSSQPSVNQKSVE | 876 | Q3KNS1 | |
| YPSDQTTAEKQSTDS | 376 | P56373 | |
| FSFNAPLKSNDSETS | 1556 | P0DJD0 | |
| VSDVNDNAPAFTQTS | 441 | Q9Y5E1 | |
| SSDSSNQAKVDNQPE | 516 | Q9HCH5 | |
| KSNSSAVPSDSQARE | 6 | P81877 | |
| ASKENNVSQPASSSS | 111 | Q02446 | |
| AATESEAQSSSQLQP | 366 | Q02446 | |
| KVNDASVNTDPATSA | 486 | Q86VP1 | |
| DSVKSSRSDSNFQVP | 426 | Q9P270 | |
| DFQELPASSKTSNSQ | 476 | Q9UMZ2 | |
| PESENNKTSNSSQVS | 241 | Q5JRA6 | |
| FNAPLKSNDSETSSV | 1566 | P0DJD1 | |
| SSKNEDASNSLISNF | 256 | Q7Z4L9 | |
| NVNENSSPEKTDATS | 1936 | Q15858 | |
| PDQEAVQSSTYKDSN | 596 | Q9Y2K2 | |
| NSVQTDLFSSTKPQE | 1226 | Q14191 | |
| SQDVSNAFSPSISKA | 126 | Q9Y6Y8 | |
| QASSSFQDSSQPAGK | 671 | P46087 | |
| DFTAQNQTENLTKSP | 1986 | Q6Q759 | |
| DQASQASTTSNPDES | 276 | Q8TEV9 | |
| ENQSTASTPTEKSFS | 1971 | Q13023 | |
| KENEFSPTNSTSQTV | 2616 | P25054 | |
| DDPESKFSQQQSFVQ | 61 | Q15642 | |
| ASFPEALSQKQTADN | 121 | Q5VXH5 | |
| TSPKVDVFNANSNLS | 746 | P09327 | |
| QENKSNAFPSTSCEN | 91 | Q96T68 | |
| SKVESDQPQNSNDAS | 3301 | Q86UP3 | |
| NSKETSQPTTATFQA | 56 | Q96BR9 | |
| SDAVSSDRNFPNSTN | 241 | P98170 | |
| STNPFADSLQINADK | 1266 | O75970 | |
| INNSNPSTSEQASDT | 411 | Q6ZNA4 | |
| FNTSDTQAQPSAAQE | 301 | Q76KD6 | |
| SSKQPAADTEASEQQ | 1531 | Q5SRE5 | |
| QDQQDPKSSSATASQ | 91 | Q5JSZ5 | |
| SVSNSASSLQKDNVP | 1161 | Q6AHZ1 | |
| EKSTNDAPSVSTFQR | 181 | Q8N823 | |
| TRPQSKDSTSVQDFS | 116 | P0CG31 | |
| QSSVTVENASKPDFT | 116 | Q8ND82 | |
| SPKKSQDNSVNFSNS | 836 | Q9Y4F4 | |
| TPNNASTKNSENVDE | 1266 | Q8IWV8 | |
| DDQPSAASSVNKAST | 326 | Q6ZS17 | |
| SDTNIFDSNVPSNKS | 86 | Q6PJT7 | |
| VSVDAPESKSESSNN | 326 | Q8NDV7 | |
| ATPTNTTNNTFANED | 1141 | Q5T200 | |
| TTEQRTDPANSQKAS | 356 | Q8WUU4 |